- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06130592
Teknisk genomförbarhetsstudie av ultraljudsmuskelavbildning vid antenatal ultraljud (FetUS)
Teknisk genomförbarhetsstudie av ultraljudsmuskelavbildning vid antenatal ultraljudsscreening av medfödd multipel artrogrypos
The objective of the study is to evaluate the performance of muscle ultrasound sections on antenatal ultrasound between 21-24 amenorrhea weeks for the screening of muscle atrophy, in a sample of low-risk and high-risk pregnancies of congenital multiple arthrogryposis
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Frequent rare diseases (100-200 births in France / year), congenital multiple arthrogryposis include a set of pathologies characterized by the limitation of joint movements at least two joint levels.Their functional prognosis and muscle atrophy are often severe after birth.
Routine ultrasound call signs are either non-specific or insensitive and difficult to detect due to time constraints. Antenatal ultrasound screening is not very effective for these pathologies, which are often particularly serious.
The main criterion will be the success rate of realization of all four ultrasound sections at the extremities (deltoide, biceps, quadriceps, triceps) and measurements of the distances "skin - muscle fascia" and "muscular fascia - periosteum" between 21-24 amenorrhea weeks
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Lora PEJOT, Midwife
- Telefonnummer: 0476766561
- E-post: lpejot@chu-grenoble.fr
Studieorter
-
-
Isère
-
La Tronche, Isère, Frankrike, 38700
- Rekrytering
- university hospital of Grenoble
-
Kontakt:
- Lora Pejot, midwife CRA
- Telefonnummer: +33 (0)4 76 76 65 61
- E-post: lpejot@chu-grenoble.fr
-
Kontakt:
- Caroline Tournegros, CRA
- Telefonnummer: +33 (0)4 76 76 72 30
- E-post: CTournegros@chu-grenoble.fr
-
Huvudutredare:
- Christine Ravier, Midwife
-
-
Rhone
-
Bron, Rhone, Frankrike, 69677
- Rekrytering
- Hopitaux Civils de Lyon - Hôpital Femme Mère Enfant
-
Kontakt:
- Mathilde Vermont, CRA
- E-post: mathilde.vermont@chu-lyon.fr
-
Kontakt:
- Jérôme Massardier, MD
- E-post: jerome.massardier@chu-lyon.fr
-
Huvudutredare:
- jérome Massardier, MD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Any pregnant woman consulting in one of the two obstetric gynecology departments in connection with the CPDPN (Multidisciplinary Prenatal Diagnostic Centers) of the University hospitals of Lyon or Grenoble.
- Mono-embryonic pregnancy.
- Gestational ages retained on the first dating ultrasound or the 1st trimester ultrasound between 21-24 amenorrhea weeks.
- For women at "high risk": diagnosis during ultrasound of the 1st, 2nd, or 3rd trimesters, of an abnormality of position / deformation of one or more joints, and / or an abnormality of fetal movements on screening ultrasound or interrogation (population group at "high risk of AMC").
- Regulatory criteria: adults, affiliated to a social security scheme, having signed a consent
Exclusion Criteria:
- Multiple pregnancies, and / or non-progressive .
- Obese women (BMI > 30 in early pregnancy)
- Subject in a period of exclusion from another study
- Subject under administrative or judicial supervision
- Subject who cannot be contacted in case of emergency
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: high risk of Arthrogryposis AMC
Patient with a diagnosis during the 1st, 2nd, or 3rd trimester ultrasound, of an abnormality of position / deformation of one or more joints, and / or an abnormality of fetal movements at screening ultrasound or interrogation |
ultrasound muscle imaging technique in antenatal ultrasound screening of congenital multiple arthrogryposis |
|
Aktiv komparator: low risk of Arthrogryposis AMC
Patient coming for screening ultrasound |
ultrasound muscle imaging technique in antenatal ultrasound screening of congenital multiple arthrogryposis |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Rate of achievement (success) of all four sections at the extremities
Tidsram: 72 hours +/- 24 hours
|
Rate of achievement (success) of all four sections at the extremities for measurements (in mm) of the distances "skin - muscular aponeurosis" and "muscular aponeurosis- periosteum" between 21-24 amenorrhea weeks |
72 hours +/- 24 hours
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Rate of achievement (success) of each four sections
Tidsram: 72 hours +/- 24 hours
|
Rate of achievement (success) of measurements (in mm) of the distances "skin - muscular aponeurosis" and "muscular aponeurosis- periosteum" between 21-24 amenorrhea weeks for biceps, deltoide, quadriceps and sural triceps |
72 hours +/- 24 hours
|
|
Collect the raisons for the failure of achievement of all sections
Tidsram: 72 hours +/- 24 hours
|
Collect the raisons for the failure of achievement of all sections (Inadequate foetal position,Insufficient echogenicity, Reasons related to the position of the limbs (full extension or flexion of the elbows or knees, abduction of the shoulder, other), other raison (to be specified) |
72 hours +/- 24 hours
|
|
Duration of realization of the ultrasound sections
Tidsram: 72 hours +/- 24 hours
|
Duration of realization of the ultrasound sections (investigators make an hypotheses of a duration of 3 minutes necessary for the realization of the sections |
72 hours +/- 24 hours
|
|
Comparison of the completion rates of all cuts during ultrasounds between high- and low-risk patients
Tidsram: 72 hours +/- 24 hours
|
Comparison of the completion rates of all cuts during ultrasounds between high- and low-risk patients |
72 hours +/- 24 hours
|
|
Concordance of measures (CCI coefficient) will be evaluated in intra-observer and inter-observer respectively
Tidsram: 72 hours +/- 24 hours
|
Concordance of measures (CCI coefficient) will be evaluated in intra-observer and inter-observer respectively by dividing by half the high-risk pregnancies, to whom it will be proposed a 2nd ultrasound of the 2nd trimester, within 3 days (±24) hours by the same / another referent sonographer in the same center. A group of 30 low-risk pregnancies will be evaluated in the same way, with the study of intra-observer reproducibility in 15. The sample of 30 pregnancies in which two measurements are made makes it possible to obtain a lower bound of the 95% confidence interval of the intra-class correlation coefficient greater than 0.7, if this coefficient is 0.85 or more. This threshold is usually considered to reflect a satisfactory concordance. |
72 hours +/- 24 hours
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Klaus DIETERICH, MD,PhD, Univ. Grenoble Alpes Inserm U1209 IAB CHU Grenoble Alpes
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 38RC21.0423
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .